Andra Krauze, M.D.
Staff Clinician

Dr. Krauze is a staff clinician in the Radiation Oncology Branch. Her clinical research interests focus on the biological and therapeutic effects of radiation administered alone and in combination with other drugs as well as inclusion of novel imaging techniques in radiation therapy planning. Dr. Krauze’s cancer sites of interest include central nervous system tumors, prostate cancer and lymphoma.

Areas of Expertise
radiation therapy, central nervous system cancers, lymphoma, prostate cancer, radiation sensitizing agents

Contact Info

Andra Krauze, M.D.

Center for Cancer Research
National Cancer Institute

Building 10-CRC, Room B2-3500
Bethesda, MD 20892
301-496-5457

Dr. Krauze received an undergraduate degree in Biochemistry from the University of Calgary, Calgary, Alberta, Canada in 2002 and her medical degree from the University of Alberta, Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada, in 2007. She completed a five year residency training program in radiation oncology with the University of Alberta and went on to join NIH as a Clinical Fellow in 2012. She is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Radiology. Dr. Krauze has conducted research on cancer cell killing by oncolytic viruses and the mechanism of interaction of various chemotherapeutic drugs. She is the author of several peer-reviewed publications and conducts clinical research on the biologic and therapeutic effect of radiation therapy involving radiosensitizing agents. She also has an interest in the incorporation of new imaging approaches into radiation therapy planning to further individualize the administration of radiation therapy as well as improve quality of life outcomes and survivorship.

Biography

Dr. Krauze received an undergraduate degree in Biochemistry from the University of Calgary, Calgary, Alberta, Canada in 2002 and her medical degree from the University of Alberta, Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada, in 2007. She completed a five year residency training program in radiation oncology with the University of Alberta and went on to join NIH as a Clinical Fellow in 2012. She is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Radiology. Dr. Krauze has conducted research on cancer cell killing by oncolytic viruses and the mechanism of interaction of various chemotherapeutic drugs. She is the author of several peer-reviewed publications and conducts clinical research on the biologic and therapeutic effect of radiation therapy involving radiosensitizing agents. She also has an interest in the incorporation of new imaging approaches into radiation therapy planning to further individualize the administration of radiation therapy as well as improve quality of life outcomes and survivorship.